Osmind Raises $2M Seed Round to Revolutionize Mental Health by Empowering Mental Health Patients, Clinicians, and Researchers
Osmind Raises $2M Seed Round to Revolutionize Mental Health by Empowering Mental Health Patients, Clinicians, and Researchers
10/14/20, 1:05 PM
Location
san franciscoMoney raised
$2 million
Round Type
seed
Osmind, a healthcare technology startup providing software and clinical insights for mental health, announced today that it raised $2M in seed funding. The fundraising round was led by General Catalyst, with participation from What If Ventures, 20|20 Fund, Jeffrey Leiden MD, PhD (Executive Chairman of Vertex Pharmaceuticals), Alice Zhang (co-founder and CEO of Verge Genomics), and a number of other prominent healthcare executives. Osmind is also backed by Y Combinator and Pear VC. The funding will accelerate the development and expansion of Osmind’s electronic health record software and analytics platform leveraged by providers and researchers working with treatment-resistant mental health populations.
Company Info
Location
san francisco, california, united states
Additional Info
Osmind is building the operating system for neuropsychiatry. Our mission is to empower clinicians and researchers to bring innovative mental health treatments to patients who need it most. Osmind’s EHR is the leading software solution designed for progressive mental health providers to track outcomes, streamline workflows, and increase client engagement for evidence-based practices. The EHR anchors a digital infrastructure that generates insights for researchers to unlock novel therapeutic approaches and precision psychiatry. For more information, visit osmind.org and join the conversation on Twitter, Instagram, and LinkedIn.